. ** The lengths of the expanded repeats are considerably shorter for SCA-6 than for the other genes, and the pathogenic mechanism may be different. (1) The normal protein, with its normal-length glutamine repeat.
(2) The expanded glutamine repeat undergoes a conformational change, presumably due to hairpin formation via a polar zipper. Interactions with other proteins such as HAP1 and HIP1 are altered, possibly resulting in pathological events within the cytoplasm.
(3) The protein with the expanded glutamine repeat undergoes proteolytic cleavage, via caspase 3 or other enzymes. Dystrophic neurites form in the cytoplasm (data not shown).
(4) The N-terminal fragment is translocated to the nucleus, where it may bind to the nuclear matrix (for ataxin-1, binding to LANP takes place in the nuclear matrix), forming a nidus for additional molecules to associate via a ␤-pleated sheet.
(5) As additional huntingtin fragments aggregate, the proteins are modified by ubiquitinization. (6) Proteins cannot be removed and form the intranuclear neuronal inclusions. Cytoplasmic aggregates can also form (data not shown), yielding dystrophic neurites.
Thus, it is remarkable that this year intranuclear incluMice with the CAG-repeat insertion developed a progressive late-onset behavioral phenotype, which insions have been identified in all four of the disorders in which they have been sought (Becher et al., 1997; DiFig- cluded ataxia, seizures, and early death. Neuropathological examination of the mice with the lia et al., Paulson et al., 1997; Skinner et al., 1997) . In each case, the inclusions have a similar appearanceectopic CAG repeats in HPRT revealed no clear neuronal cell death, but intranuclear inclusions were evident when well-demarcated structures ‫2ف‬ m across without a surrounding membrane and distinct from the nucleolus.
labeled with antibodies to the HPRT protein or ubiquitin. Thus, CAG repeats translated into polyglutamine, even Some neurons may have two or three inclusions, but most neurons have only one. Furthermore, in HD, in in an ectopic protein without neurological function, can produce a progressive neurological phenotype accomwhich a sufficient number of cases have been studied, there is a clear correlation between increasing CAGpanied by the formation of intranuclear inclusions. This confirms that polyglutamine can directly yield aggregarepeat length and increasing density of the inclusions (Becher et al., 1997) . In all of these disorders, the inclution and supports the idea that intranuclear neuronal inclusions are pathogenic. When taken together, these sions can be labeled with antibodies to the disease protein product itself or with antibodies to ubiquitin.
results raise a number of questions.
What Is in the Nucleus and How Does Ectopic CAG Repeats
All of these results are consistent with the idea that It Get There? HPRT is a relatively small protein of ‫84ف‬ kDa, including expanded stretches of polyglutamine can be toxic. However, they do not rule out the possibility that other comthe polyglutamine. Therefore, Ordway et al. (1997) propose that it enters the nucleus by diffusion, consistent ponents of the disease gene products might be necessary. The question remains: what would happen if with the cutoff of ‫05ف‬ kDa for passive exchange of proteins between nucleus and cytoplasm. It is also pospolyglutamine were expressed ectopically in the context of a nonpathogenic protein? This experiment has now sible that passive diffusion accounts for the entry of ataxin-3 into the nucleus, though with the expanded been performed by Detloff and colleagues (Ordway et al., 1997) . A long CAG repeat was inserted into the CAG repeat it runs on a denaturing gel as a protein of nearly 70 kDa (Paulson et al., 1997) . Presumably larger mouse hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene, which codes a metabolic enzyme.
proteins would have to be translocated actively into the nucleus. Ataxin-1 has a nuclear import signal and is the GST appeared to inhibit formation of aggregates. When the protein was cleaved from the GST, aggregate normally enriched in the nucleus-especially in cerebellar Purkinje cells, the cells most affected in SCA-1.
formation was enhanced. The differences in sensitivity to repeat number in the different diseases (Gusella et Ataxin-7 is present in nuclear fractions and also has a nuclear localization signal. Similarly, the androgen real., 1997) could be due in part to a similar context effect. Do Intranuclear Inclusions Kill Cells? ceptor of spinal and bulbar muscular atrophy (SBMA) undergoes nuclear translocation on binding of andro-
The intranuclear neuronal inclusions are now strong candidates for a central role in the pathogenesis of all gen. However, the nuclear localization of the inclusions in HD and dentato-rubral and pallido-luysian atrophy of the glutamine-repeat diseases. Consistent with this is the distribution of the inclusions in brains of patients (DRPLA) are not accounted for, since both huntingtin and atrophin 1 are large proteins without any nuclear with the various disorders. For instance, in HD the inclusions are enriched in medium-sized neurons of the strialocalization signals. How might they enter the nucleus?
For huntingtin, there is evidence that proteolytic protum and neurons of layers III, V, and VI of the cerebral cortex, which are all selectively vulnerable in HD. They cessing may be involved. Huntingtin can be cleaved by caspase 3, one of the proteases involved in triggering are found less often in other brain regions and rarely, if at all, in nonneuronal cells (Becher et al., 1997; DiFiglia apoptosis (Goldberg et al., 1996) . It is possible that the other glutamine-repeat proteins may also be cleaved by et al. , 1997) . Similarly, in DRPLA and in SCA-1 and SCA-3, the inclusions appear to be enriched in the most this or related enzymes. , 1997) .
In transgenic mice, the data are also consistent with internal sequences (Becher et al., 1997; DiFiglia et al., 1997) . Furthermore, a ‫04ف‬ kDa huntingtin fragment reca role for the inclusions in the development of the phenotype. In the ataxin-1 transgenic mice, the inclusions are ognized by the N-terminal antibody is enriched in nuclear fractions of brains from patients with HD (DiFiglia present before the onset of the phenotype, and the neurons later degenerate. Similarly, in the HD exon-1 transet al. , 1997) . Thus, it is quite likely that, at least for huntingtin, what accumulates is predominantly a small, genic mice, the inclusions are present before the onset of the earliest behavioral symptoms (Davies et al., 1997) . truncated fragment of the protein. A necessary pathogenic event in HD therefore may be proteolytic cleavage
In both the HD exon-1 model and in the HPRT model, inclusions are present in great number, but neuronal cell by caspase, other proteolytic enzymes, or both.
However, even if the small portion of huntingtin can death cannot be demonstrated. It is possible that the inclusions in this case cause neuronal dysfunction long enter the nucleus, why should it aggregate there? One must also ask why other proteins that are normally cytobefore neuronal death. The mouse model of SCA-1 clearly indicates that neuronal dysfunction long preplasmic aggregate in the nucleus. Recent data may provide an answer for SCA-1. Yeast two-hybrid methods ceeds detectable neuronal death. Interestingly, occasional HD patients are reported who have had clear were used to identify a nuclear protein, the leucinerich acidic nuclear protein (LANP), which binds far more symptoms prior to death but have no qualitatively detectable neuronal loss in the striatum. effectively to ataxin-1 with an expanded repeat than it does to ataxin-1 with a normal repeat (Matilla et al., Nevertheless, the arguments linking intranuclear inclusions to cell death rest on correlation. As Ordway et 1997) . The two proteins colocalize in subdomains of the nucleus termed nuclear bodies (Matilla et al., 1997) . By al. (1997) point out, it is equally conceivable that the inclusions are merely a marker for some other process contrast, a number of other proteins present in other subdomains of the nucleus did not colocalize with that is actually responsible for the neuronal cell death. Conversely, the inclusions might be an attempt by the ataxin-1 (Skinner et al., 1997) . Thus, binding to ataxin-1 appears to alter the distribution of LANP within the nucell to defend against polyglutamine toxicity, and they might actually exercise a protective role. These issues cleus and to make the two together bind tightly to the nuclear matrix. It is possible that other nuclear binding could be addressed in cell-transfection experiments, by designing constructs with nuclear localization or nuclear proteins, perhaps related to LANP, may aggregate with truncated portions of other glutamine-repeat disease export signals strategically placed to increase or decrease the concentration of polyglutamine repeats in proteins. However, it is unclear if such protein interactions could explain the preferential aggregation of the the nucleus. Even if intranuclear inclusions were to have a caus-HPRT protein with its ectopically located glutamine repeat. At least for the interaction of ataxin-1 and LANP, ative role in neuronal cell death and dysfunction, the mechanism remains unclear. The inclusions appear to other portions of the protein besides the glutamine repeat itself appear to be critically involved. How HPRT be relatively circumscribed and to exclude DNA (Davies et al., 1997) , suggesting that they don't physically disrupt is recruited to nuclear inclusions, therefore, is uncertain.
In addition to possibly affecting where protein aggrethe chromatin in the nucleus. They may, however, have more subtle effects on gene transcription. For instance, gates, in some way the "context" provided by other portions of the disease proteins appears to influence it is conceivable that they could alter transcription of genes required for neuronal viability, perhaps including the ability of the polyglutamine to aggregate. In in vitro aggregation experiments, the polyglutamine-containing glutamate receptors, mitochondrial proteins, or other molecules previously implicated in neuronal vulnera-HD exon-1 construct was fused to glutathione S-transferase (GST; Scherzinger et al. , 1997) . In this complex, bility.
As noted above, the distribution of intranuclear inclusions in brains from patients with several of the diseases Ross, C.A. (1995) . Neuron 15, [493] [494] [495] [496] appears to match the distribution of pathology in these
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G.P., Davies, S.W., Lehrach, H., and diseases, despite the fact that the mutant proteins are
Wanker, E.E. (1997 distribution of expression of LANP in normal brain corresponds quite closely to the pattern of vulnerability in SCA-1 (Matilla et al., 1997) . This suggests a role for LANP in specifying neuronal vulnerability by forming a nidus for aggregation. A second possibility is that protein cleavage itself is a cell type-specific event. Experiments directed at this issue will be necessary to resolve the factors governing differential vulnerability of cells to protein aggregation.
Relation to Other Neurodegenerative Disorders
The unexpected discovery of inclusion bodies in the polyglutamine disorders, and the clear demonstration that polyglutamine-containing proteins can aggregate, indicate that these polyglutamine disorders are more similar to each other than was previously anticipated and may be related to other neurodegenerative disorders. As is described in the accompanying review (Lansbury, 1997 [this issue of Neuron]), protein aggregation is a common mechanism in other late-onset neurodegenerative diseases, including Alzheimer's disease, prion disease, and Parkinson's disease. Shared mechanisms or shared biological modifiers may underlie several of these diseases. Cross-fertilization among investigators working on these various disorders is bound to lead to rapid advances in our understanding of the pathogenesis of these diseases.
